Disappointing sales of Sanofi’s PraluentLes Echos reported on Monday (p.18) that despite interesting clinical trial results, sales of Sanofi's Praluent (alirocumab) were disappointing.
French trust drugs more than pharma companiesLes Echos reported on Wednesday (p.20) that according to the annual survey carried out on the subject by French pharma Leem and the Ipsos Institute, eight out of 10 French people trust medicines.
Novartis to spin off AlconLe Figaro reported in a brief on Thursday (p.22) that Novartis has started the process to spin off its eyecare business Alcon (APMHE 60569).
Merck KGaA to invest in French siteGerman pharma Merck KGaA is to invest €19 million in its factory in north-central France which manufactures oral diabetes drugs, reported Le Figaro in a brief on Thursday (p.22).
Sanofi to invest €20 million in 'digital transformation' of factoriesLes Echos reports on Friday that Sanofi is to invest €20 million in the digital transformation of factories between now and 2021.
French biotech Transgène to market first treatment in 2021Le Figaro reported on Thursday (p.24) that French biotech Transgène has opened a mini-factory in France to produce its made-to-measure cancer vaccine, Myvac.
Samsung BioLogics accused of rigging its accountsLes Echos reported on Thursday (p.23) that Samsun BioLogics is accused of having rigged its accounts just before it was listed on the Seoul stock exchange (APMHE 60572).
Merck KGaA lowers annual sales forecastLes Echos reported in a brief on Thursday (p.18) that Merck KGaA has lowered its annual sales forecast after a fall in sales in Q3.
Antibiotic resistance is health industry’s new challengeLes Echos reported on Monday (p.18) that growing antibiotic resistance is the health industry’s biggest challenge and is one of the World Health Organisation’s (WHO) main priorities.
Phage therapy to combat antibiotic resistanceLe Parisien reports on Friday (front page, p. 2-3) on phage therapy, a kind of therapy that uses viruses to tackle the most serious infections where antibiotics do not work.
New head for French national medical research instituteLe Figaro reported in a brief on Wednesday (p.12) that Gilles Bloch, head of Paris-Saclay university, will be appointed head of the French national medical research institute (Inserm).
Increase in percentage of infants vaccinated against meningococcal CLe Monde Science & Medicine reported on Wednesday (p.3) that the percentage of infants vaccinated against meningococcal C had increased by 31 percentage points since the obligation to vaccinate children was extended in France at the beginning of 2018.
Pasteur Institute's 130th anniversaryLe Parisien reports on Friday (p.11) on 130 years of the Pasteur Institute, and what the so-called “lab rats” do on a day-to-day basis.
TRY APM HEALTH EUROPE AND GET ACCESS TO THE FULL CONTENT
Interviews with KOLs/senior executives amongst the Regulators, Payers, Health, Medical & Pharmaceutical organisations
Events coverage with a unique focus on Market Access & sustainability of healthcare systems
6 European bureaus : Berlin, Brussels, London, Madrid, Milan & Paris
Ask for a Free trial and get access to our last stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.